feng lin5
liked
$LQR House (LQR.US)$
LQR House Inc. Announces 5700% Year-Over-Year Revenue Growth for September 2024
LQR House Inc. (NASDAQ:LQR), a niche ecommerce platform in the spirits and beverage industry, has reported a 5700% year-over-year revenue increase for September 2024. The company's revenue grew from $3,800 in September 2023 to $222,584.72 in September 2024.
CEO Sean Dollinger attributed this significant growth to the increasing momentum of their platform CWSpirits.com and recent new partnershi...
LQR House Inc. Announces 5700% Year-Over-Year Revenue Growth for September 2024
LQR House Inc. (NASDAQ:LQR), a niche ecommerce platform in the spirits and beverage industry, has reported a 5700% year-over-year revenue increase for September 2024. The company's revenue grew from $3,800 in September 2023 to $222,584.72 in September 2024.
CEO Sean Dollinger attributed this significant growth to the increasing momentum of their platform CWSpirits.com and recent new partnershi...
2
1
$Antelope Enterprise (AEHL.US)$ We're taking off now.
Translated
$Aditxt (ADTX.US)$ Fly up.
Translated
$Aditxt (ADTX.US)$ 2.9 went in.
Translated
1
2
$Fangdd Network (DUO.US)$ Same as xhg yesterday.
Translated
1
feng lin5
commented on
$MicroAlgo (MLGO.US)$ MM's want it dropped to load more if none of em take that from each other or something sparks a run
3
feng lin5
liked
$VivoPower (VVPR.US)$ This Merger will Send this!!!
3
feng lin5
commented on
$Fangdd Network (DUO.US)$ Sold at a loss of 700, goodbye.
Translated
7
feng lin5
liked
$CytomX (CTMX.US)$
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
1
feng lin5
liked
$Faraday Future Intelligent Electric Inc. (FFIE.US)$ Heaven has a road, but you don't walk. Hell has no door, but you came on your own.
Translated
8
2